Botanical species · safety record

Montanoa tomentosa

The EFSA Compendium of Botanicals holds 14 constituent measurements and 5 adverse-effect records for Montanoa tomentosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Montanoa tomentosa Cerv.

14Constituent measurements
5Safety records
11Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Guaianolides5
  • Diterpenes2
  • Sesquiterpene lactones2
  • Germacranolide1
  • Isoquercitrin1
  • Kaurenoic acids1
  • Montanol1
  • Zoapatanol1

Plant parts

  • Leaves15
  • Aerial part of plants4

Preparations

  • Solvent extraction19

Effect types

  • Developmental4
  • Reproductive1

Target tissues

  • Uterus4
  • Urogenital1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
DiterpenesLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
DiterpenesLeavesSolvent extractionResolve DOI
GuaianolidesLeavesSolvent extraction0.009 PercentNuclear Magnetic Resonance (NMR)Resolve DOI
GuaianolidesLeavesSolvent extraction0.0022 PercentNuclear Magnetic Resonance (NMR)Resolve DOI
GuaianolidesLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
GuaianolidesLeavesSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
GuaianolidesLeavesSolvent extraction0.0027 PercentNuclear Magnetic Resonance (NMR)Resolve DOI
Kaurenoic acidsLeavesSolvent extractionResolve DOI
MontanolLeavesSolvent extractionGaschromatography (GC)Resolve DOI
Sesquiterpene lactonesAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
ZoapatanolLeavesSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
GermacranolideAerial part of plantsSolvent extractionNo resolvable identifier
IsoquercitrinLeavesSolvent extraction0.0018 PercentColorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
Sesquiterpene lactonesAerial part of plantsSolvent extractionNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
DevelopmentalUterusLeavesSolvent extractionGuinea pig (as animal)Reproduction toxicityResolve DOI
DevelopmentalUterusLeavesSolvent extractionRat (as animal)Reproduction toxicityResolve DOI
DevelopmentalUterusLeavesSolvent extractionGuinea pig (as animal)Reproduction toxicityResolve DOI
DevelopmentalUterusLeavesSolvent extractionHouse mouse (as animal)Reproduction toxicityResolve DOI
ReproductiveUrogenitalAerial part of plantsSolvent extractionRat (as animal)Reproduction toxicityResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. HAHN, DW., ERICSON, EW., LAI, MT., PROBST, A. ANTI-FERTILITY ACTIVITY OF MONTANOA-TOMENTOSA (ZOAPATLE). Contraception, 1981, vol. 23, no. 2, p. 133-140. DOI
  2. Carro-Juarez, M., Cervantes, E., Cervantes-Mendez, M., Rodriguez-Manzo, G. Aphrodisiac properties of Montanoa tomentosa aqueous crude extract in male rats . Pharmacology biochemistry and behavior, 2004, vol. 78, no. 1, p. 129-134. DOI
  3. LIDIAPEREZ, A., CABALLERO, MBA., ORTEGA, A., GAVINO, R., DEVIVAR, AR. NEW SESQUITERPENE LACTONES FROM MONTANOA-TOMENTOSA SUBSP XANTHIIFOLIA. Planta medica, 1994, vol. 60, no. 3, p. 263-266. DOI
  4. KANOJIA, RM., WACHTER, MP., LEVINE, SD., ADAMS, RE., CHEN, R., CHIN, E., COTTER, ML., HIRSCH, AF., HUETTEMANN, R., KANE, VV., OSTROWSKI, P., SHAW, CJ., MATEOS, JL., NORIEGA, L., GUZMAN, A., MIJAREZ, A., TOVAR, L., SHEFTER, E. ISOLATION AND STRUCTURAL ELUCIDATION OF ZOAPATANOL AND MONTANOL, NOVEL OXEPANE DITERPENOIDS FROM THE MEXICAN PLANT ZOAPATLE (MONTANOA-TOMENTOSA) . Journal of organic chemistry, 1982, vol. 47, no. 7, p. 1310-1319. DOI
  5. Braca, A., Cioffi, G., Morelli, I., Venturella, F., Pizza, C., De Tommasi, N. Two new sesquiterpene lactones from Montanoa tomentosa ssp microcephala. Planta medica, 2001, vol. 67, no. 8, p. 774-776.
  6. QUIJANO, L., GOMEZ, F., SIERRA, E., RIOS, T. ACYCLIC DITERPENES AND SESQUITERPENE LACTONES FROM MONTANOA-TOMENTOSA SUBSP TOMENTOSA . Phytochemistry, 1991, vol. 30, no. 6, p. 1947-1950. DOI
  7. Enriquez, RG., Miranda, E., Ortiz, B., Leon, I., Magos, G., Pena, A., Reynolds, WF., Gnecco, D. The unambiguous detection of kaurenic derivatives in aqueous infusions of Montanoa tomentosa by GC-MS and 2D-NMR spectroscopy: An answer to contradictory reports . Planta medica, 1996, vol. 62, no. 6, p. 569-571. DOI
  8. TOPCU, G., CORDELL, GA., FARNSWORTH, NR., FONG, HHS. STUDIES ON ZOAPATLE .8. NOVEL CYTO-TOXIC SESQUITERPENE LACTONES FROM MONTANOA-TOMENTOSA SSP MICROCEPHALA . Journal of pharmaceutical sciences, 1988, vol. 77, no. 6, p. 553-556. DOI
  9. QUIJANO, L., CALDERON, JS., GOMEZ, F., RIOS, T. ZOAPATANOLIDE-A AND ZOAPATANOLIDE-B, 2 NEW HELIANGOLIDES FROM MONTANOA-TOMENTOSA . Phytochemistry, 1982, vol. 21, no. 8, p. 2041-2044. DOI
  10. Oshima, Yoshiteru., Gordell, Geoffrey A., Fong, Harry H. S. Studies on zoapatle. III. Flavonoid glycosides from Montanoa tomentosa ssp. tomentosa. Journal of natural products, 1986, vol. 49, no. 3, p. 551-2.
  11. MARCELLE, GB., BUNYAPRAPHATSARA, N., CORDELL, GA., FONG, HHS., NICOLAOU, KC., ZIPKIN, RE. STUDIES OF ZOAPATLE .1. THE EXTRACTION OF ZOAPATLE (MONTANOA-TOMENTOSA) AND THE IDENTIFICATION OF 21-NORMONTANOL AS THE INITIAL DECOMPOSITION PRODUCT OF ZOAPATANOL . Journal of natural products, 1985, vol. 48, no. 5, p. 739-745. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue